Deutsche Forschungsgemeinschaft
- "Corticosteroid
receptor-mediated control of endocrine adipocyte function", 2007-2009
- "Neurohumoral regulation of adipose tissue
function", 2004-2006
- "Regulation of energy
homeostasis and insulin resistance by the sympathetic nervous
system, leptin, and insulin", 2000-2003
- "Crosstalk between
adrenergic and insulin signaling systems", 1997-1999
Bundesministerium für Bildung und Forschung
- "Adipose transdifferentiation and
mineralocorticoid receptor modulation", 2008-2010
Teilprojekt im
Kompetenznetz Adipositas
Alexander von Humboldt-Stiftung
- "Incretin crosstalk with
adipose tissue", Feodor-Lynen-Fellowship, 2004-2007
Deutsche Diabetes Gesellschaft
- "Molecular mechanisms of
insulin resistance and obesity", 2000-2002
Translationale Forschungsförderung durch die Industrie
- "Charakterisierung differentieller
Fettgewebsdepotfunktionen"
Beiersdorf, Exp. Forschung, Hamburg, Deutschland, 2007-2008
- "Molecular And
Functional Analyses Using A Native Knock-Out Cell System For Cb-1
And Cb2 Cannabinoid Receptors"
Aventis-Sanofi, Research and Development, Paris & Berlin, France &
Germany,
2006-2007
- "The
Endocannabinoid-System: Molecular and Clinical Target for Controlling Metabolic
&
Endocrine Fat Cell
Function"
Aventis-Sanofi,
Research and Development, Paris & Berlin, France & Germany,
2006-2007
- "Modulation of Adipocyte Function by
Incretins, DPP-IV, and DPP-IV Inhibitors: Clinical
Targets of Drug Development"
Novartis, Biomedical Research, Cambridge, USA, 2004-2006
- "Atorvastatin interaction with adipose
tissue function"
Pfizer, Research &
Development, New York, USA, 2004-2005
Medizinische Fakultät der Universität Lübeck
- "Regulation der
Adipogenese durch das Inkretin GIP", 2007-2008
- "Regulation der Fettgewebsfunktion
in vivo", 2003-2005
-
Schwerpunktförderung "Glukose und Gehirn", 2002-2004
-
Schwerpunktförderung "Metabolisches Syndrom", 2000-2002
- "Mechanismen
sympatho-adrenerger Regulation des Energiestoffwechsels",
1999-2000
|
